Phase 1 Cutaneous T Cell Lymphoma Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
Peripheral T Cell LymphomaAnaplastic Large Cell LymphomaMycosis Fungoides+7 more
National Cancer Institute (NCI)60 enrolled1 locationNCT07055477
Recruiting
Phase 1
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
Mycosis FungoidesCutaneous T Cell Lymphoma
University of Alabama at Birmingham10 enrolled1 locationNCT05414500
Recruiting
Phase 1
Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
Cutaneous T Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute38 enrolled1 locationNCT07047885
Recruiting
Phase 1Phase 2
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Ossium Health, Inc.12 enrolled9 locationsNCT05589896
Recruiting
Phase 1
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
Cutaneous T Cell Lymphoma
Memorial Sloan Kettering Cancer Center20 enrolled3 locationsNCT05296304
Recruiting
Phase 1
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
T-cell LymphomaPeripheral T Cell LymphomaMycosis Fungoides+8 more
SciTech Development, Inc.46 enrolled10 locationsNCT04234048
Recruiting
Phase 1
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
Peripheral T Cell LymphomaCutaneous T Cell Lymphoma (CTCL)NHL (Non-Hodgkin Lymphoma)
Tianjin Medical University Cancer Institute and Hospital24 enrolled1 locationNCT06914037